ID

27379

Description

Safety Study of XL147 (SAR245408), in Combination With Paclitaxel and Carboplatin in Adults With Solid Tumors; ODM derived from: https://clinicaltrials.gov/show/NCT00756847

Link

https://clinicaltrials.gov/show/NCT00756847

Keywords

Versions (1)
  1. 11/10/17 11/10/17 -
Copyright Holder

See clinicaltrials.gov

Uploaded on

November 10, 2017

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Cancer NCT00756847

English

Eligibility Cancer NCT00756847

1 forms  
  1. StudyEvent: Eligibility
    1. Eligibility Cancer NCT00756847
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
confirmed diagnosis of:
Description

Diagnosis

Data type

boolean

Alias
UMLS CUI [1]
C0011900
advanced solid tumor that is no longer responding to therapies or
Description

Solid tumour Advanced Unresponsive to Treatment

Data type

boolean

Alias
UMLS CUI [1,1]
C0280100
UMLS CUI [1,2]
C0205179
UMLS CUI [1,3]
C0205269
advanced or recurrent endometrial carcinoma or
Description

Endometrial Carcinoma Advanced | Recurrent Endometrial Cancer

Data type

boolean

Alias
UMLS CUI [1,1]
C0476089
UMLS CUI [1,2]
C0205179
UMLS CUI [2]
C0278802
advanced or recurrent ovarian carcinoma or
Description

Ovarian Carcinoma Advanced | Ovarian cancer recurrent

Data type

boolean

Alias
UMLS CUI [1,1]
C0029925
UMLS CUI [1,2]
C0205179
UMLS CUI [2]
C0278689
unresectable (stage iiib or iv) nsclc
Description

Non-Small Cell Lung Carcinoma unresectable TNM clinical staging

Data type

boolean

Alias
UMLS CUI [1,1]
C0007131
UMLS CUI [1,2]
C1519810
UMLS CUI [1,3]
C3258246
ecog performance status 0-1 (ecog status of 2 may be considered following discussion and agreement with sponsor)
Description

ECOG performance status

Data type

boolean

Alias
UMLS CUI [1]
C1520224
adequate organ and bone marrow function as defined by hematological and serum chemistry limits
Description

Organ function Hematologic | Bone Marrow function Hematologic | Organ function Serum Chemistry Measurement | Bone Marrow function Serum Chemistry Measurement

Data type

boolean

Alias
UMLS CUI [1,1]
C0678852
UMLS CUI [1,2]
C0205488
UMLS CUI [2,1]
C0005953
UMLS CUI [2,2]
C0031843
UMLS CUI [2,3]
C0205488
UMLS CUI [3,1]
C0678852
UMLS CUI [3,2]
C1883010
UMLS CUI [4,1]
C0005953
UMLS CUI [4,2]
C0031843
UMLS CUI [4,3]
C1883010
at least 18 years old
Description

Age

Data type

boolean

Alias
UMLS CUI [1]
C0001779
both men and women must practice adequate contraception
Description

Contraceptive methods

Data type

boolean

Alias
UMLS CUI [1]
C0700589
informed consent
Description

Informed Consent

Data type

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
restriction of some therapies/medications within specific timeframes prior to enrollment and during the study including prior therapy with pi3k, akt, or mtor inhibitors, cytotoxic chemotherapy, biologic agents, nitrosoureas or mitomycin c, small-molecule kinase inhibitors, non-cytotoxic hormonal agents
Description

PI3K | AKT | mTOR Inhibitor | Cytotoxic Chemotherapy | Biological Factors | Nitrosoureas | Mitomycin | Other Coding | Non-Cytotoxic Agent Hormonal

Data type

boolean

Alias
UMLS CUI [1]
C0044602
UMLS CUI [2]
C0164786
UMLS CUI [3]
C2746052
UMLS CUI [4]
C0677881
UMLS CUI [5]
C0005515
UMLS CUI [6]
C0028210
UMLS CUI [7]
C0002475
UMLS CUI [8]
C3846158
UMLS CUI [9,1]
C2827065
UMLS CUI [9,2]
C0458083
known allergy or hypersensitivity to any of the components of the treatment formulations
Description

Hypersensitivity Investigational New Drugs Component

Data type

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0013230
UMLS CUI [1,3]
C1705248
taking oral corticosteroids chronically or > 1 mg/day warfarin
Description

Adrenal Cortex Hormones Oral chronic | Warfarin U/day

Data type

boolean

Alias
UMLS CUI [1,1]
C0001617
UMLS CUI [1,2]
C1527415
UMLS CUI [1,3]
C0205191
UMLS CUI [2,1]
C0043031
UMLS CUI [2,2]
C0456683
not recovered from the toxic effects of prior therapy
Description

Toxic effect Due to Prior Therapy | Recovery Lacking

Data type

boolean

Alias
UMLS CUI [1,1]
C0600688
UMLS CUI [1,2]
C0678226
UMLS CUI [1,3]
C1514463
UMLS CUI [2,1]
C2004454
UMLS CUI [2,2]
C0332268
history of diabetes mellitus.
Description

Diabetes Mellitus

Data type

boolean

Alias
UMLS CUI [1]
C0011849
uncontrolled intercurrent illness
Description

Comorbidity Uncontrolled

Data type

boolean

Alias
UMLS CUI [1,1]
C0009488
UMLS CUI [1,2]
C0205318
pregnant or breastfeeding
Description

Pregnancy | Breast Feeding

Data type

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
congestive heart failure, unstable angina, or a myocardial infarction within 3 months of entering the study.
Description

Congestive heart failure | Angina, Unstable | Myocardial Infarction

Data type

boolean

Alias
UMLS CUI [1]
C0018802
UMLS CUI [2]
C0002965
UMLS CUI [3]
C0027051
hiv positive
Description

HIV Seropositivity

Data type

boolean

Alias
UMLS CUI [1]
C0019699
diagnosis of another malignancy may exclude subject from study
Description

Cancer Other

Data type

boolean

Alias
UMLS CUI [1]
C1707251
Back to the top of the page

Similar models

Eligibility Cancer NCT00756847

1 forms
  1. StudyEvent: Eligibility
    1. Eligibility Cancer NCT00756847
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Diagnosis
Item
confirmed diagnosis of:
boolean
C0011900 (UMLS CUI [1])
Solid tumour Advanced Unresponsive to Treatment
Item
advanced solid tumor that is no longer responding to therapies or
boolean
C0280100 (UMLS CUI [1,1])
C0205179 (UMLS CUI [1,2])
C0205269 (UMLS CUI [1,3])
Endometrial Carcinoma Advanced | Recurrent Endometrial Cancer
Item
advanced or recurrent endometrial carcinoma or
boolean
C0476089 (UMLS CUI [1,1])
C0205179 (UMLS CUI [1,2])
C0278802 (UMLS CUI [2])
Ovarian Carcinoma Advanced | Ovarian cancer recurrent
Item
advanced or recurrent ovarian carcinoma or
boolean
C0029925 (UMLS CUI [1,1])
C0205179 (UMLS CUI [1,2])
C0278689 (UMLS CUI [2])
Non-Small Cell Lung Carcinoma unresectable TNM clinical staging
Item
unresectable (stage iiib or iv) nsclc
boolean
C0007131 (UMLS CUI [1,1])
C1519810 (UMLS CUI [1,2])
C3258246 (UMLS CUI [1,3])
ECOG performance status
Item
ecog performance status 0-1 (ecog status of 2 may be considered following discussion and agreement with sponsor)
boolean
C1520224 (UMLS CUI [1])
Organ function Hematologic | Bone Marrow function Hematologic | Organ function Serum Chemistry Measurement | Bone Marrow function Serum Chemistry Measurement
Item
adequate organ and bone marrow function as defined by hematological and serum chemistry limits
boolean
C0678852 (UMLS CUI [1,1])
C0205488 (UMLS CUI [1,2])
C0005953 (UMLS CUI [2,1])
C0031843 (UMLS CUI [2,2])
C0205488 (UMLS CUI [2,3])
C0678852 (UMLS CUI [3,1])
C1883010 (UMLS CUI [3,2])
C0005953 (UMLS CUI [4,1])
C0031843 (UMLS CUI [4,2])
C1883010 (UMLS CUI [4,3])
Age
Item
at least 18 years old
boolean
C0001779 (UMLS CUI [1])
Contraceptive methods
Item
both men and women must practice adequate contraception
boolean
C0700589 (UMLS CUI [1])
Informed Consent
Item
informed consent
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
PI3K | AKT | mTOR Inhibitor | Cytotoxic Chemotherapy | Biological Factors | Nitrosoureas | Mitomycin | Other Coding | Non-Cytotoxic Agent Hormonal
Item
restriction of some therapies/medications within specific timeframes prior to enrollment and during the study including prior therapy with pi3k, akt, or mtor inhibitors, cytotoxic chemotherapy, biologic agents, nitrosoureas or mitomycin c, small-molecule kinase inhibitors, non-cytotoxic hormonal agents
boolean
C0044602 (UMLS CUI [1])
C0164786 (UMLS CUI [2])
C2746052 (UMLS CUI [3])
C0677881 (UMLS CUI [4])
C0005515 (UMLS CUI [5])
C0028210 (UMLS CUI [6])
C0002475 (UMLS CUI [7])
C3846158 (UMLS CUI [8])
C2827065 (UMLS CUI [9,1])
C0458083 (UMLS CUI [9,2])
Hypersensitivity Investigational New Drugs Component
Item
known allergy or hypersensitivity to any of the components of the treatment formulations
boolean
C0020517 (UMLS CUI [1,1])
C0013230 (UMLS CUI [1,2])
C1705248 (UMLS CUI [1,3])
Adrenal Cortex Hormones Oral chronic | Warfarin U/day
Item
taking oral corticosteroids chronically or > 1 mg/day warfarin
boolean
C0001617 (UMLS CUI [1,1])
C1527415 (UMLS CUI [1,2])
C0205191 (UMLS CUI [1,3])
C0043031 (UMLS CUI [2,1])
C0456683 (UMLS CUI [2,2])
Toxic effect Due to Prior Therapy | Recovery Lacking
Item
not recovered from the toxic effects of prior therapy
boolean
C0600688 (UMLS CUI [1,1])
C0678226 (UMLS CUI [1,2])
C1514463 (UMLS CUI [1,3])
C2004454 (UMLS CUI [2,1])
C0332268 (UMLS CUI [2,2])
Diabetes Mellitus
Item
history of diabetes mellitus.
boolean
C0011849 (UMLS CUI [1])
Comorbidity Uncontrolled
Item
uncontrolled intercurrent illness
boolean
C0009488 (UMLS CUI [1,1])
C0205318 (UMLS CUI [1,2])
Pregnancy | Breast Feeding
Item
pregnant or breastfeeding
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Congestive heart failure | Angina, Unstable | Myocardial Infarction
Item
congestive heart failure, unstable angina, or a myocardial infarction within 3 months of entering the study.
boolean
C0018802 (UMLS CUI [1])
C0002965 (UMLS CUI [2])
C0027051 (UMLS CUI [3])
HIV Seropositivity
Item
hiv positive
boolean
C0019699 (UMLS CUI [1])
Cancer Other
Item
diagnosis of another malignancy may exclude subject from study
boolean
C1707251 (UMLS CUI [1])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial